Viral and protozoal vaccines.
Monoclonal antibodies

At the centre of the CIBEX platform is the unicellular ciliate microorganism tetrahymena thermophila. Due to its outstanding properties, it is considered a "workhorse" in the life sciences.

In addition to the endeavour to optimise the CIBEX platform for the general production of therapeutic enzymes, Cilian is also developing therapeutic proteins in three different sectors.


Tetravalent protein sub-unit vaccine for the treatment of seasonal and pandemic flu

Ciliate Lipase

Recombinant lipase enzyme - e.g. for the treatment of exocrine pancreatic insufficiency (EPI)


Production of monoclonal antibodies based on the CIBEX expression system.

Contact us

Contact us with any questions and find information on how to contact us. We would like to hear from you!